Express News | Clover Health Sees FY24 Adj. EBITDA Profitability $55M-$65M
Clover Health Investments Backs FY24 Insurance Rev $1.35B-$1.375B>CLOV
Clover Health Investments 3Q Rev $331M >CLOV
Clover Health GAAP EPS of -$0.02 Beats by $0.02, Revenue of $331M Misses by $15.27M
Express News | Clover Health Investments Q3 Revenue USD 322.6 Million
Press Release: Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership
Clover Health Options Imply 13.9% Move in Share Price Post-earnings
Health Insurers Climb After Trump Win
CLOV Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
Earnings Preview: CLOV to Report Financial Results Post-market on November 06
Clover Health to Participate in Upcoming Investor Conferences
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
How Is The Market Feeling About Clover Health Investments?
Clover Health Investments, Corp. (NASDAQ:CLOV) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Clover Health to Report Third Quarter 2024 Financial Results on November 6
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Clover Health Investments, Oklo to Advance
Jim Cramer On Clover Health Investments, Corp. (CLOV): 'I Just Don't Want To Go There'
Clover Health Options Spot-On: On October 17th, 98,417 Contracts Were Traded, With 350.93K Open Interest
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories